Optimizing therapy for nodal marginal zone lymphoma.

@article{Thiblemont2016OptimizingTF,
  title={Optimizing therapy for nodal marginal zone lymphoma.},
  author={Catherine Thi{\'e}blemont and Thierry Jo Molina and Frederic Davi},
  journal={Blood},
  year={2016},
  volume={127 17},
  pages={2064-71}
}
Nodal marginal zone lymphoma (NMZL) is a rare form of indolent small B-cell lymphoma which has only been clearly identified in the last 2 decades and which to date remains incurable. Progress in therapeutic management has been slow, largely due to the very small number of patients treated and the heterogeneity of treatments administered; thus, standard-of-care treatment is currently nonspecific for this lymphoma entity. In this review, treatments routinely used to manage adult NMZL patients are… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS
5 Extracted Citations
89 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 89 references

The coding genome of nodal marginal zone lymphoma reveals recurrent molecular alterations of PTPRD and other Jak/Stat signaling genes

  • V Spina, H Khiabanian, A Bruscaggin
  • Abstract 705. ASH. Blood
  • 2014
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…